http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103083409-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7efc0c9253e97418d0d116bb0d1d84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
filingDate 2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c05fda8f489f337d207d726d947daefd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af4083c259f1e12e78ae3a1d11801df9
publicationDate 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103083409-A
titleOfInvention Oral liquid treating psoriasis
abstract Belonging to the technical field of traditional Chinese medicine preparation, the invention relates to an oral liquid treating psoriasis and its preparation method. The oral liquid is mainly prepared from the following components by weight: 100-300g of natural indigo, 100-300g of lithospermum, and 200-300g of licorice. For the adopted three traditional Chinese medicines, the natural indigo can clear away heat and toxic materials, dispel wind and eliminate dampness; the lithospermum can remove pathogenic heat from blood, and promote blood circulation to remove blood stasis; and the licorice has the efficacy of nourishing blood and moisturizing skin, tonifying qi and strengthening the spleen. Directed at the etiological factors of disharmony between spleen and stomach, stagnation and congestion of qi and blood, blood heat and blood stasis causing psoriasis, the three herbal medicines can achieve the synergistic efficacy of removing pathogenic heat from blood, promoting blood circulation to remove blood stasis, nourishing blood and moisturizing skin. In the invention, the three herbal medicines are processed into an oral liquid, the medicines are small in variety and easy to collect, the treatment method is simple and painless, and no toxic or side effect exists. Thus, the oral liquid is easily accepted by mass patients.
priorityDate 2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 15.